Scandion Oncology A/S new share issue oversubscribed
On October 18, 2018, the subscription period for Scandion Oncology A/S’s new share issue of approx. SEK 26 million prior to listing on Spotlight Stock Market was completed. Scandion Oncology received subscription for a total of approx. SEK 104.7 million. This corresponds to a total subscription ratio of approx. 402.7 percent. Through the new share issue, Scandion Oncology will receive approx. 1 500 new shareholders.
The Press Release can be viewed her:Scandion Oncology A/S new share issue oversubscribed